Correction: CDKL3 promotes osteosarcoma progression by activating Akt/PKB
{{output}}
This study demonstrates that CDKL3 regulates Akt activation and its downstream targets to promote OS progression, creating a therapeutically targetable vulnerability in treatment of OS. ... ...
